In contrast, Yogasundaram et al. observed that ERT-treated FD patients revealed higher levels of TNF, TNFR1, TNFR2, MMP-2, and lyso-Gb3 compared to those not under ERT [54] (Figure 3). The gene discussed is MMP2; the disease is Fabry disease.